Organox
Organox40
Organox
Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.
About
What does Organox do?
Organox is a medical technology company focused on developing and commercializing devices for organ preservation and assessment. Their primary product, the Organ Care System (OCS), is designed to keep donor organs viable outside the body for longer periods, allowing for better assessment and potentially increasing the number of successful transplants. They target transplant centers and medical professionals involved in organ transplantation.
What is Organox's valuation?
StartupHub estimates Organox's effective valuation at $144.4M (range $95.0M to $228.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Organox raised?
Organox has raised a total of $38M in funding.
Where is Organox headquartered?
Organox is headquartered in Oxford, United Kingdom.
What industry does Organox operate in?
Organox operates in MedTech, Biotech, Medical Devices, Organ Transplantation, Organ Preservation, Surgical Technology.
“Revolucia v transplantaciach: OrganOx ziskava 142 milionov na expanziu!.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.